< em > NF2 < /em > is a candidate diagnosis, prognostic, and immunotherapeutic biomarker: a systematic pan-cancer analysis
CONCLUSIONS: Our study reveals that NF2 might be helpful in tumor early diagnosis and prognosis evaluation. The expression of NF2 is highly associated with the tumor immune microenvironment. Additionally, NF2 is a potential biomarker for predicting the efficacy of immune checkpoint inhibitors therapy. Therefore, NF2 can be a promising diagnostic, prognostic, and immunotherapeutic biomarker for many types of tumors.PMID:38482423 | PMC:PMC10928596 | DOI:10.21037/tcr-23-1179
Source: Cell Research - Category: Cytology Authors: Honglu Zhang Jiyong Liu Source Type: research
More News: Allergy & Immunology | Asbestosis | Brain | Breast Cancer | Cancer | Cancer & Oncology | Cytology | Genetics | Lymphoma | Men | Mesothelioma | Neurology | Ovarian Cancer | Ovaries | Study